148 related articles for article (PubMed ID: 35421421)
1. Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma.
Ravindran A; Kurtin PJ; King RL; Yuan J; Feldman AL; Rech KL; McPhail ED; Parikh SA; Ding W; Shi M
Hum Pathol; 2022 Jul; 125():2-10. PubMed ID: 35421421
[TBL] [Abstract][Full Text] [Related]
2. Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma.
Lyapichev KA; Sakhdari A; Khoury JD; O'Malley DP; El Hussein S; Yin CC; Patel KP; Thakral B; Young KH; Medeiros LJ; Konoplev S
Ann Diagn Pathol; 2020 Dec; 49():151636. PubMed ID: 32977233
[TBL] [Abstract][Full Text] [Related]
3. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
[TBL] [Abstract][Full Text] [Related]
4. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
5. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
[TBL] [Abstract][Full Text] [Related]
6. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
7. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
[TBL] [Abstract][Full Text] [Related]
9. Canonical and non-canonical Wnt signal pathway in classic Hodgkin lymphoma and the prognostic significance of LEF1, β-catenin, FZD6 and Wnt5a/b.
Gao L; Cui W; Kelting S; Woodroof J; Li H; Li L; Zhang D
Am J Blood Res; 2022; 12(4):136-143. PubMed ID: 36147604
[TBL] [Abstract][Full Text] [Related]
10. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
Tian X; Xu J; Dorfman DM
Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
[TBL] [Abstract][Full Text] [Related]
11. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
Jamroziak K; Tadmor T; Robak T; Polliack A
Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
[TBL] [Abstract][Full Text] [Related]
12. Geographic Variability of Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Xia D; Sayed S; Moloo Z; Gakinya SM; Mutuiri A; Wawire J; Okiro P; Courville EL; Hasserjian RP; Sohani AR
Am J Clin Pathol; 2022 Feb; 157(2):231-243. PubMed ID: 34542569
[TBL] [Abstract][Full Text] [Related]
13. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
Wu D; Thomas A; Fromm JR
Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
[TBL] [Abstract][Full Text] [Related]
14. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
15. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma.
Wlodarska I; Nooyen P; Maes B; Martin-Subero JI; Siebert R; Pauwels P; De Wolf-Peeters C; Hagemeijer A
Blood; 2003 Jan; 101(2):706-10. PubMed ID: 12393409
[TBL] [Abstract][Full Text] [Related]
16. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma.
Liso A; Capello D; Marafioti T; Tiacci E; Cerri M; Distler V; Paulli M; Carbone A; Delsol G; Campo E; Pileri S; Pasqualucci L; Gaidano G; Falini B
Blood; 2006 Aug; 108(3):1013-20. PubMed ID: 16614247
[TBL] [Abstract][Full Text] [Related]
17. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
[TBL] [Abstract][Full Text] [Related]
18. Additional characterization of LEF1 expression in nodular lymphocyte predominant Hodgkin lymphoma and classic Hodgkin lymphoma.
Rea B; Bailey NG
Ann Diagn Pathol; 2021 Jun; 52():151730. PubMed ID: 33743303
[No Abstract] [Full Text] [Related]
19. Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma.
Linke F; Harenberg M; Nietert MM; Zaunig S; von Bonin F; Arlt A; Szczepanowski M; Weich HA; Lutz S; Dullin C; Janovská P; Krafčíková M; Trantírek L; Ovesná P; Klapper W; Beissbarth T; Alves F; Bryja V; Trümper L; Wilting J; Kube D
Leukemia; 2017 Feb; 31(2):361-372. PubMed ID: 27535218
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection patterns in nodular lymphocyte-predominant Hodgkin lymphoma.
Gerhard-Hartmann E; Jöhrens K; Schinagl LM; Zamó A; Rosenwald A; Anagnostopoulos I; Rosenfeldt M
Histopathology; 2022 Jun; 80(7):1071-1080. PubMed ID: 35322462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
